English
全部
搜索
图片
视频
地图
资讯
更多
购物
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
订购者
最佳匹配
最新鲜
生物通
16 天
丹参酮 IIA或为抗肺癌 “新武器”:通过 PI3K-AKT-mTOR 通路影响 MMP7 ...
为探究丹参酮 II A 对耐紫杉醇非小细胞肺癌 A549/Tax 的作用,研究发现其或通过 PI3K-AKT-mTOR 通路影响 MMP7 表达抑制细胞增殖。 肺癌,这个全球范围内的 “健康杀手”,在 2022 年新确诊病例高达 248.03 万,雄踞各类癌症榜首,每年因肺癌丧生的人数超 180 万。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
New tariff warning to China
US stocks plunge
Minivan crashes into crowd
South Sudan visas revoked
Former Steelers player dies
Child star dies at 73
Plastic contamination recall
Retires after 13 seasons
Texas AG launches probe
Houthis: US strikes kill 6
Iconic bassist Allen dies
Finalize 14-yr, $500M deal?
UConn wins NCAA title
Georgia car accident
RU reduces prison sentence
CBP officers charged
Tortilla chips recalled
Israel controls 50% of Gaza
Former NCAA president dies
Pirates to restore sign
California hantavirus death
Japanese Grand Prix win
Parental proxy voting deal
Dimon on US tariffs
4 girls stabbed in Brooklyn
First marathon in six years
Releases new AI models
RFK Jr. urges vaccination
Appears at St. Peter's Square
反馈